Schizophrenia: Violence and comorbidity

Current Opinion in Psychiatry

Volumn 12, Issue 1, 1999, Pages 47-51

  Citrome, Leslie ^a   Volavka, Jan ^b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE;

COMORBIDITY; FEMALE; HUMAN; HUMAN GENETICS; MALE; MENTAL DISEASE; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; VIOLENCE;

EID: 0032998967     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199901000-00016     Document Type: Review

References (30)

1. Wallace C, Mullen P, Burgess P, Palmer S, Ruschena D, Browns C. Serious criminal offending and mental disorder. Br J Psychiatry 1998; 172:477-484. The authors describe a case linkage study using well-established public records, with nature of offenses, including homicide, property offenses, sexual offending, arson, drug-related offenses, and traffic offenses, clearly demarcated.
2. Rasaren P, Tiihonen J, Isohanni M, Rantakallio P, Lehtonen J, Moring J. Schizophrenia, alcohol abuse, and violent behaviour: a 26-year follow-up of an unselected birth cohort. Schizophrenia Bulletin 1998; 24:437-441. This technique is a valuable one, and has provided important information on the epidermiology of psychiatric disorders.
3. Steadman HJ, Mulvey EP, Monahan J, Robbins PC, Appelbaum PS, Grisso T, et al. Violence by people discharged from acute psychiatric inpatient facilities and others in the same neighborhoods. Arch Gen Psychiatry 1998; 55:393-401. Data from the influential MacArthur Violence Risk Assessment Study is presented. This research group has published extensively in this area. This particular paper is being utilized to support the controversial notion that patients with schizophrenia alone are no more dangerous than their neighbors in the community. However, methodologic problems weaken the conclusions.
4. Czobor P, Volavka J. Violence in the mentally ill: questions remain [letter]. Arch Gen Psychiatry (in press).
5. Stueve A, Link BG. Violence and psychiatric disorders: results from an epidemiological study of young adults in Israel. Psychiatr Quart 1997; 68:327-342. Psychotic patients comprised only a small portion of the total sample.
6. Pal S. Mental disorders in abnormal offenders in Papua New Guinea. Med Law 1997; 16:87-95.
7. Volavka J, Laska E, Baker S, Meisner M, Czobor P, Krivelevich I. History of violent behavior and schizophrenia in different cultures. Br J Psychiatry 1997; 171:9-14. These analyses are based on the World Health Organization study on Determinants of Outcome of Severe Mental Disorders, initiated in 1978, and conducted at 13 field research centers across the world.
8. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry 1998; 155:226-231. This research group has published extensively in the field of mental disorder, substance abuse, and community violence. This report is based on data collected as part of a randomized clinical trial that examined the effectiveness of involuntary outpatient commitment and case management in reducing noncompliance with psychiatric treatment, and preventing relapse, rehospitalization, and other poor outcomes among the severely mentally ill.
9. Fulwiler C, Grossman H, Forbes C, Ruthazer R. Early-onset substance abuse and community violence by outpatients with chronic mental illness. Psychiatr Serv 1997; 48:1181-1185. The authors make the intriguing conclusion that early-onset substance abuse predicts violent behavior better than adult-onset substance abuse.
10. Voruganti LNP, Heslegrave RJ, Awad AG. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. J Nerv Mental Dis 1997; 185:463-465. The authors provide a screening guide for neuroleptic dysphoria.
11. Regier D, Farmer M, Rae D, Lockie BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990; 264:2511-2518.
12. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96:329-333.
13. Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR. Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Arch Gen Psychiatry 1997; 54:706-712. The authors contend that the negative syndrome predicts compliance with treatment.
14. Kirchner JE, Owen RR, Nordquist C, Fischer EP. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatr Serv 1998; 49:82-85. The authors described patients with schizophrenia and co-occurring substance use disorders, but whose substance use disorders go undetected, and thus untreated, in facilities that are most likely to serve this population.
15. Mueser KT, Drake RE, Ackerson TH, Alterman AI, Miles KM, Noordsy DL. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia. J Abnorm Psychol 1997; 106:473-477. The authors examine the validity of subtypes of schizophrenia with co-occurring substance use disorders, based on the presence of antisocial personality disorder or history of conduct disorder.
16. Cheung P, Schweitzer I, Yastrubetskaya O, Crowley K, Tuckwell V. Studies of aggressive behaviour in schizophrenia: is there a response bias? Med Sci Law 1997; 37:345-348. Patients who refuse to participate, are judged too ill to participate, or judged as too aggressive to participate in studies examining aggressive behavior will bias the results of any such study. The authors described the characteristics of these patients.
17. Volavka J, Citrome L. Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns. Schizophr Res (in press). The authors describe in detail the methodologic considerations in planning a study of aggressive behavior. They review the current literature on the utility of atypical antipsychotics for aggressive behavior in patients with schizophrenia.
18. Cheung P, Schweitzer I, Crowley K, Tuckwell V. Violence in schizophrenia: role of hallucinations and delusions. Schizophr Res 1997; 26:181-190. The authors found that affective response to hallucinations is more useful in predicting violent behavior than the simple presence of hallucinations, including those of the command type.
19. Cheung P, Schweitzer I, Crowley K, Tuckwell V. Aggressive behavior in schizophrenia: role of state versus trait factors. Psychiatry Res 1997; 72:41-50. This article should be read alongside [16].
20. Cheung P, Schweitzer I, Crowley K, Tuckwell V. Aggressive behavior in schizophrenia: the role of psychopathology. Aust NZ J Psychiatry 1997; 31:62-67.
21. Junginger J, Parks-Levy J, McGuire L. Delusions and symptom-consistent violence. Psychiatr Serv 1998; 49:218-220.
22. Buchanan A. The investigation of acting on delusions as a tool for risk assessment in the mentally disordered. Br J Psychiatry 1997; 170 (Suppl 32): 12-16.
23. Krakowski M, Czobor P. Violence in psychiatric patients: the role of psychosis, frontal lobe impairment, and ward turmoil. Comp Psychiatry 1997; 38:230-236. The authors built upon their prior work and further described their classification of violent patients into either transiently or persistently violent groups.
24. Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 1998; 59 (Suppl 3):8-14. A comprehensive review.
25. Spivak B, Mester R, Wittenberg N, Maman Z, Weizman A. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients. Clin Neuropharmacol 1997; 20:442-446.
26. Beck NC, Greenfield SR, Gotham H, Menditto AA, Stuve P, Hemme CA. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility. J Am Acad Psychiatry Law 1997; 25:461-468. The sample studied by the authors consists of severely impaired forensic patients.
27. Cantillon M, Goldstein JM. Quetiapine fumarate reduces aggression and hostility in patients with schizophrenia. New Research Poster NR444. American Psychiatric Association 1998 Annual Meeting, Toronto, Ontario, Canada, May 30-June 4 1998.
28. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. Analysis of a functional catechol O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 1997; 69:71-77. This paper presents the first report of an association between COMT polymorphism and aggression in schizophrenia.
29. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998; 155:835-837. This is a replication of the paper by Strous et al. [28] in a different patient sample using a more stringent definition of violence.
30. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 1998; 95:9991-9996.